Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism.
Mourtada R, Fonseca SB, Wisnovsky SP, Pereira MP, Wang X, Hurren R, Parfitt J, Larsen L, Smith RA, Murphy MP, et al. PLoS One. 2013; 8(4):e60253. Epub 2013 Apr 9.